“Join us for a webinar for Cancer Awareness Month! We will hear from Dr. Anand Mehta, who will present some of the findings outlined in a recent paper highlighting the development and application of a new biomarker platform that can contribute to the detection of hepatocellular carcinoma (HCC) while the disease is still in its earliest stages and is more treatable and less deadly. We hope you can join us to learn more about this cutting-edge work and its widespread implications!”